Abstract Views
PDF Download

Perception, Knowledge and Adherence to Antiretroviral Theraphy (ART) among Mother PLHIV in Yogyakarta

Pages 1-11


Based on WHO 2019, there were 38 million people living with HIV (PLHIV), this figure has increased by 24% compared 2010. Globally more women were living with HIV in 2019 than men. In the same year, 85% of women and girls globally had acces to antiretroviral therapy (ART) to prevent mother-to-child transmission (MTCT). However, high ART coverage levels do not reflect the continued transmission that occurs after women are initially counted as receiving treatment. The purpose of this study was to know perception, knowledge and adherence ART. This research was quantitative research with crosssectional desaign. The research was conducted at the Victory Plus Foundation in 2020. The number of respondents in this study was mothers with HIV who had toddler as 39 respoden. Majority of respondents are 20-35 years old, senior high school education, housewives, married, last delivery by section cesarean and children with negative HIV. Majority of respondents have good knowledge, perception of HIV has positive and adherence to ARV theraphy.

There is no Figure or data content available for this article


  • S. N. Green, “Seizing the moment,” Sur, vol. 14, no. 26, pp. 73–82, 2017, doi: 10.2307/j.ctt7svxh.14.
  • World Health Organization, “Latest HIV estimates and updates on HIV policies uptake,” Glob. HIV, Hepat. STI Program., no. November, pp. 1–40, 2020.
  • WHO, “Mother-to-child transmission of HIV,” WHO, 2019. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/prevention/mother-to-child-transmission-of-hiv
  • UNICEF, “Prevention of Mother-To-Child Transmission of HIV The key to ensure that no child is born with HIV,” 2019. https://www.unicef.org/indonesia/prevention-mother-child-transmission-hiv
  • K. RI, Infodating Pusat Data dan Informasi Kementerian Kesehatan RI. Jakarta, 2020.
  • Dinkes Kota Yogyakarta, “Profil Dinas Kesehatan Kota Yogyakarta tahun 2020,” Profil Dinas Kesehat. Kota Yogyakarta tahun 2019, pp. 1–234, 2020.
  • WHO, Available From HIV/AIDS. 2020.
  • WHO, Global Health Sector Strategy on HIV 2016-2021, no. June 2016. 2016.
  • L. W. Green and M. W. Kreuter, “Helath promotion planning-An educational and ecological approach.pdf,” p. 298.
  • J. P. Meyer and N. Haven, “Women’s Intersectional Risks for HIV and Incarceration and Implications for Interventions,” J Womens Heal., vol. 30, no. 5, pp. 630–631, 2022, doi: 10.1089/jwh.2020.8841.Women.
  • R. N. Philemon et al., “Do women enrolled in PMTCT understand the recommendations: A case study from Kilimanjaro,” Patient Prefer. Adherence, vol. 15, pp. 1301–1309, 2021, doi: 10.2147/PPA.S307847.
  • S. A. Hurst, K. E. Appelgren, and A. P. Kourtis, “Prevention of mother-to-child transmission of HIV Type 1: The role of neonatal and infant prophylaxis,” Expert Rev. Anti. Infect. Ther., vol. 13, no. 2, pp. 169–181, 2015, doi: 10.1586/14787210.2015.999667.
  • Kemenkes, Pedoman Pelaksanaan Pencegahan Penularan HIV dan Sifilis dari Ibu ke Anak bagi Petugas Kesehatan. Kemenkes, 2015. [Online]. Available: https://siha.kemkes.go.id/portal/files_upload/Manlak_PPIA_2015.pdf
  • R. Schaefer, R. Thomas, C. Nyamukapa, R. Maswera, N. Kadzura, and S. Gregson, “Accuracy of HIV Risk Perception in East Zimbabwe 2003–2013,” AIDS Behav., vol. 23, no. 8, pp. 2199–2209, 2019, doi: 10.1007/s10461-018-2374-0.
  • A. A. S. Sawitri, I. N. Sutarsa, T. P. Merati, M. Bakta, and D. N. Wirawan, “Perceptions dynamics about antiretroviral treatment among hiv patients in Bali,” Int. J. Public Heal. Sci., vol. 10, no. 3, pp. 500–507, 2021, doi: 10.11591/ijphs.v10i3.20917.
  • E. Ukaegbu, R. Alibekova, S. Ali, B. Crape, and A. Issanov, “Trends of HIV/AIDS knowledge and attitudes among Nigerian women between 2007 and 2017 using Multiple Indicator Cluster Survey data,” BMC Public Health, vol. 22, no. 1, pp. 1–12, 2022, doi: 10.1186/s12889-022-12865-y.
  • T. Hastuti, “Hubungan Dukungan Terhadap Kepatuhan Minum Antiretroviral pada Ibu Rumah Tangga dengan HIV AIDS,” Ekp, vol. 13, no. 3, pp. 1576–1580, 2017.
  • M. Barton Laws, Y. Lee, W. S. Rogers, T. Taubin, and I. B. Wilson, “An instrument to assess HIV-related knowledge and adjustment to HIV+ status, and their association with anti-retroviral adherence,” PLoS One, vol. 15, no. 6 June, pp. 1–11, 2020, doi: 10.1371/journal.pone.0227722.
  • F. Latif, I. L. Maria, and M. Syafar, “Efek Samping Obat terhadap Kepatuhan Pengobatan Antiretroviral Orang dengan HIV/AIDS,” Kesmas Natl. Public Heal. J., vol. 9, no. 2, p. 101, 2014, doi: 10.21109/kesmas.v9i2.495.
  • S. Andini, S. Yona, and A. Waluyo, “Self-efficacy, depression, and adherence to antiretroviral therapy (ART) among Indonesian women with HIV,” Enferm. Clin., vol. 29, 2019, doi: 10.1016/j.enfcli.2019.04.105.
  • O. V. Adeniyi, A. I. Ajayi, D. Ter Goon, E. O. Owolabi, A. Eboh, and J. Lambert, “Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa,” BMC Infect. Dis., vol. 18, no. 1, pp. 1–11, 2018, doi: 10.1186/s12879-018-3087-8.
  • F. Nurfalah, S. Yona, and A. Waluyo, “The relationship between HIV stigma and adherence to antiretroviral (ARV) drug therapy among women with HIV in Lampung, Indonesia,” Enferm. Clin., vol. 29, pp. 234–237, 2019, doi: 10.1016/j.enfcli.2019.04.138.
  • T. D. Mastro, N. Sista, and Q. Abdool-Karim, “ARV-based HIV prevention for women - Where we are in 2014,” J. Int. AIDS Soc., vol. 17, no. 3, 2014, doi: 10.7448/IAS.17.3.19154.
  • R. Burhan, “Pemanfaatan Pelayanan Kesehatan oleh Perempuan Terinfeksi HIV/AIDS,” Kesmas Natl. Public Heal. J., vol. 8, no. 1, p. 33, 2013, doi: 10.21109/kesmas.v8i1.339.
  • Y. Yuniar, R. S. Handayani, and N. K. Aryastami, “Faktor –Faktor Pendukung Kepatuhan Orang Dengan Hiv Aids (Odha) Dalam Minum Obat Antiretroviral Di Kota Bandung Dan Cimahi,” Bul. Penelit. Kesehat., pp. 72–83, 2013.
  • D. Suryaningdiah, “Rekomendasi Upaya Peningkatan Kepatuhan Pengobatan Arv Di Kota Surabaya,” J. Penelit. Kesehat. “SUARA FORIKES” (Journal Heal. Res. “Forikes Voice”), vol. 7, no. 1, pp. 27–31, 2016.
  • H. Li et al., “The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis,” AIDS Behav., vol. 21, no. 2, pp. 341–351, 2017, doi: 10.1007/s10461-016-1545-0.
  • M. A. S. Mbengue, S. O. Sarr, A. Diop, C. T. Ndour, B. Ndiaye, and S. Mboup, “Prevalence and determinants of adherence to antiretroviral treatment among HIV patients on first-line regimen: A cross-sectional study in Dakar, Senegal,” Pan Afr. Med. J., vol. 33, pp. 1–13, 2019, doi: 10.11604/pamj.2019.33.95.17248.
There is no Supplemental content for this article.

How to Cite This

Setiyawati, N., & Meilani, N. (2023). Perception, Knowledge and Adherence to Antiretroviral Theraphy (ART) among Mother PLHIV in Yogyakarta. International Conference on Health Sciences, 10(1), 1–11. https://doi.org/10.29238/ichs.v10i1.2054

Article Metrics

Download Statistics

Other Statistics

Verify authenticity via CrossMark

Copyright and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Data Availability